Recent advances of transcriptomics and proteomics in triple‐negative breast cancer prognosis assessment

Triple‐negative breast cancer (TNBC), a heterogeneous tumour that lacks the expression of oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2), is often characterized by aggressiveness and tends to recur or metastasize. TNBC lacks therapeutic target...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yuan, Kong, Xiangyi, Wang, Zhongzhao, Xuan, Lixue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899180/
https://www.ncbi.nlm.nih.gov/pubmed/35150062
http://dx.doi.org/10.1111/jcmm.17124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899180/
https://www.ncbi.nlm.nih.gov/pubmed/35150062
http://dx.doi.org/10.1111/jcmm.17124

Ejemplares similares